Biotech & pharma
Why birds don’t spread Lassa fever
04 Jul 2014
Researchers regrow human corneas; could reverse blindness
04 Jul 2014
Boston researchers have identified a way to enhance regrowth of human corneal tissue to restore vision, using a molecule that acts as a marker for hard-to-find limbal stem cells
NMR provides fresh atomic insights into a key protein that helps repair DNA
03 Jul 2014
Scientists have made an important advance in understanding how a protein that identifies and repairs cancerous cells operates
Controlling movement with light
By By Anne Trafton | MIT News Office | 30 Jun 2014
Research finds cell division synchronised to cell and body’s daily clock
28 Jun 2014
The finding could optimise timing of chemotherapy and explain the occurrence of some cancers
The brain’s balancing act
26 Jun 2014
Growing unknown microbes one by one
25 Jun 2014
Stem cells hold keys to body’s plan
21 Jun 2014
For the first time in the lab, researchers see stem cells take initial step toward development
21 Jun 2014
New study pinpoints 'Lemur' protein as main player in spread of breast cancer
18 Jun 2014
Researchers have confirmed the role of a protein called Lemur Tyrosine Kinase 3 in the spread of breast cancer to other parts of the body.
A vaccination to prevent heart attacks?
16 Jun 2014
Researchers have developed a “genome editing” approach for permanently reducing cholesterol levels in mice with a single injection, potentially reducing heart attack risk by up to 90 percent
Leptin also influences brain cells that control appetite: Yale research
By By Karen N. Peart | 03 Jun 2014
Leptin’s effect on metabolism has been found to control the brain’s neuronal circuits, but no previous studies have definitively found that leptin could control the behavior of cells other than neuron
Extensive cataloguing uncovers 193 unknown human proteins
31 May 2014
The cataloging project, led by researchers at The Johns Hopkins University and the Institute of Bioinformatics in Bangalore, should prove an important resource for biological research and medical diagnostic
Latest articles
Featured articles
The remarkable Ratan Tata
By Kiron Kasbekar | 23 Oct 2024
One newspaper report of Ratan Tata’s passing away showed an old photo of him climbing into the cockpit of a Lockheed Martin F-16 fighter.
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation